Growth inhibitory effects and mechanisms of lapatinib, a dual inhibitor of ErbB1 and ErbB2 tyrosine kinase, in gastric cell lines

被引：0
|
作者：
Kim, J. W. [1 ]
Im, S. A. [2 ]
Kim, H. P. [3 ]
Oh, D. Y. [2 ]
Kim, T. Y. [2 ]
Bang, Y. J. [2 ]
机构：
[1] Seoul Natl Univ, Seoul, South Korea
[2] Seoul Natl Univ, Internal Med & Canc Res Inst, Seoul, South Korea
[3] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea
来源：
EJC SUPPLEMENTS | 2007年 / 5卷 / 04期
关键词：
D O I：
10.1016/S1359-6349(07)71012-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3509
引用
收藏
页码：262 / 262
页数：1
相关论文
共 50 条
  • [11] Lapatinib (GW572016): A novel approach to inhibit ErbB1/ErbB2
    不详
    TOXICOLOGIC PATHOLOGY, 2005, 33 (07) : 813 - 814
  • [12] Dual ErbB1 and ErbB2 receptor tyrosine kinase inhibition exerts synergistic effect with conventional chemotherapy in pancreatic cancer
    Singla, Smit
    Pippin, James A.
    Drebin, Jeffrey A.
    ONCOLOGY REPORTS, 2012, 28 (06) : 2211 - 2216
  • [13] A First Synthesis of [18F]Lapatinib: A Potential Tracer for Positron Emission Tomographic Imaging of ErbB1/ErbB2 Tyrosine Kinase Activity
    Falguni, Basuli
    Wu Haitao
    Li Changhui
    Shi Zhen-Dan
    Agnieszka, Sulima
    Gary, Griffiths L.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2011, 54 : S474 - S474
  • [14] Ploidy, expression of erbB1, erbB2, P53 and amplification of erbB1, erbB2 and erbB3 in non-small cell lung cancer
    Reinmuth, N
    Brandt, B
    Kunze, WP
    Junker, K
    Thomas, M
    Achatzy, R
    Scheld, HH
    Semik, M
    EUROPEAN RESPIRATORY JOURNAL, 2000, 16 (05) : 991 - 996
  • [15] Combined antitumor efficacies of TAK-285, a novel ErbB1/ErbB2 dual kinase inhibitor, with other anticancer drugs
    Tamura, T.
    Takagi, S.
    Horikoshi, K.
    Yusa, T.
    Koyama, M.
    Tojo, H.
    Ohta, Y.
    EJC SUPPLEMENTS, 2008, 6 (12): : 100 - 101
  • [16] The growth inhibitory effect of lapatinib, a dual inhibitor of EGFR and HER2 tyrosine kinase, in gastric cancer cell lines
    Kim, Jin Won
    Kim, Hwang-Phill
    Im, Seock-Ah
    Kang, Soyeong
    Hur, Hyung Seok
    Yoon, Young-Kwang
    Oh, Do-Youn
    Kim, Jee Hyun
    Lee, Dong Soon
    Kim, Tae-You
    Bang, Yung-Jue
    CANCER LETTERS, 2008, 272 (02) : 296 - 306
  • [17] A first synthesis of 18F-radiolabeled lapatinib: a potential tracer for positron emission tomographic imaging of ErbB1/ErbB2 tyrosine kinase activity
    Basuli, Falguni
    Wu, Haitao
    Li, Changhui
    Shi, Zhen-Dan
    Sulima, Agnieszka
    Griffiths, Gary L.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2011, 54 (9-10): : 633 - 636
  • [18] Simultaneous inhibition of ErbB1 and ErbB2 signaling significantly enhances the growth suppression of rat and human cholangiocarcinoma cell lines
    Zhang, Zichen
    Sirica, Alphonse Eugene
    FASEB JOURNAL, 2007, 21 (05): : A71 - A72
  • [19] Evaluation of AZD8931, an Equipotent Inhibitor of erbB1, erbB2, and erbB3 Receptor Signaling, on Ligand Stimulated Breast Cancer Cell Lines with Differing Levels of erbB2 Expression
    Marshall, G.
    Klinowska, T. C. M.
    Mills, E. A.
    Ogilvie, D.
    Hickinson, D. M.
    Speake, G.
    CANCER RESEARCH, 2009, 69 (24) : 784S - 785S
  • [20] Spatial Structure of the Transmembrane Domain Heterodimer of ErbB1 and ErbB2 Receptor Tyrosine Kinases
    Mineev, Konstantin S.
    Bocharov, Eduard V.
    Pustovalova, Yulia E.
    Bocharova, Olga V.
    Chupin, Vladimir V.
    Arseniev, Alexander S.
    JOURNAL OF MOLECULAR BIOLOGY, 2010, 400 (02) : 231 - 243
12345